NewsGSK & Spero Therapeutics Reports Early Conclusion of P-III (PIVOT-PO) Trial of Tebipenem HBr for Complicated Urinary Tract Infections (cUTIs) ByRidhi Rastogi3 days ago0Comments
NewsAlcon Reports the US FDA’s Approval of Tryptyr to Treat Dry Eye DiseaseByRidhi Rastogi3 days ago0Comments
NewsThe US FDA Grants Priority Review to Bayer’s Sevabertinib for HER2-mutant NSCLCByRidhi Rastogi3 days ago0Comments
NewsSNAP Biosciences Licenses Monarch Therapeutics’ Technology to Advance Snap-Car NK Cell Therapy for Cancer TargetsByRidhi Rastogi3 days ago0Comments
NewsAlvotech Expands its Partnership with Advanz Pharma to Commercialize Three Additional Biosimilars in the EUByRidhi Rastogi3 days ago0Comments
NewsRezolute Reports Enrollment Completion in P-III (sunRIZE) Trial of Ersodetug for Congenital HyperinsulinismByRidhi Rastogi3 days ago0Comments
NewsMerck KGaA to Present P-III (MANEUVER) Trial Data of Pimicotinib for Tenosynovial Giant Cell Tumor at ASCO 2025ByRidhi Rastogi4 days ago0Comments
